COCH Envoy Medical, Inc.
HealthcareAs of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
4.63
P/S
63.02
EV/EBITDA
0.41
DCF Value
$0.03
FCF Yield
-140.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
-310.7%
Operating Margin
-9881.2%
Net Margin
-9875.6%
ROE
239.4%
ROA
-77.5%
ROIC
-130.0%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $39.0K | $-4.4M | $— |
| Q4 null | $75.0K | $-6.6M | $— |
| FY null | $241.0K | $-23.8M | $— |
| Q3 null | $42.0K | $-6.5M | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$6.00
Target (Median)
$6.00
Target Range
$6.00 - $6.00
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
1.90
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.